A group of new and existing backers have provided cash to Galecto, based on research from the universities of Lund and Edinburgh.

Each Friday the Global Corporate Venturing Deal Net rounds up the week’s smaller deals and tracks the emerging companies accessing corporate funds.

Owl Insights secured funding from Blue Venture Fund and Ascension Ventures to advance its product development and distribution.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

UW mental health spinout Owl Insights secured funding to advance its product development and distribution.

Cancer drug developer Silverback has secured $211m to date from investors including BMS, Celgene and Alexandria Real Estate Equities.

Alsa Ventures is targeting a $150m final close for its inaugural biotherapeutics fund, which has already backed university-linked companies.

Existing investors Johnson & Johnson and WuXi AppTec have returned to take part in the neurological drug developer’s latest funding.

UCSF spinout Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.

Siolta Therapeutics picked up SymBiosis and Kirin Holdings in a round set to fund efficacy trials of its potential asthma treatment.